Biochemical, Biomarker and Genetic testing for Rare Diseases and beyond. From Inborn Errors of Metabolism to Oncology.
Our complete Parameter Catalogue is available now via our WEBPORTAL: Please sign-up here at webportal.archimedlife.com (for physicians only).
Why choose ARCHIMEDlife as your diagnostic laboratory partner?
Contact us for information about any laboratory tests: firstname.lastname@example.org. We are continually expanding our parameter catalogue.
Stay in touch with us and register for our ARCHIMEDlife Newsletter.
Please see below for our current services or contact us for any other laboratory test.
We are dedicated to providing diagnostics for Rare Disorders and continuously improving and expanding our services.
We offer diagnostics for:
Lysosomal Storage Disorders: Enzymatic and genetic testing including biomarkers. Click here for our comprehensive LSD diagnostic panel.
Mucopolysaccharidosis Panel: A novel enyzme test plus genetics using one drop of blood. Click here for more information.
Fabry Program: Enyzme and genetic testing plus biomarker testing for Lyso-GL-3 (Lyso-Gb3). Click here for more information.
Gaucher Program: Enzyme, genetic and biomarker testing for Gaucher disease plus Niemann-Pick A/B (ASMD) and acid Lipase deficiency (Wolman; LAL-D). Click here for more information.
Neuronal Ceroid Lipofuscinoses: Enzymatic and genetic testing using a single Dried Blood Spot card. Click here for more information.
Gangliosidoses: Enzymatic and genetic testing using a single Dried Blood Spot card. Click here for more information.
Cerebrotendinous Xanthomatosis. Novel diagnostics including biochemical (small molecule) and genetic confirmatory testing. Click here for more information.
Amino acid and Acylcarnitine profiles for Aminoacidurias, Organoacidurias and Fatty Oxidation Metabolism.
Biochemical tests. From Methylmalonic to Homocysteine.
Genetic panel for confirmatory testing. We offer a broad spectrum with our experts to provide you all the genetic information you need.
(Dietary) Monitoring. Follow-up testing using Dried Blood Spots or other body fluids.
The early detection of diseases can be life-saving and lead to best clinical outcome. We offer advanced Newborn Screening programs and tests including confirmatory testing.
In more complicated cases where a baby needs more than one of our standard screening options, we offer:
Nearly all can be performed using the initial Dried Blood Spot card.
Find out more about our Newborn Screening Programs. Click here.
Single programs available:
We offer comprehensive genetic testing for inherited cancer genes. You may choose for testing of:
We provide molecular profiling of your tumor samples. You may send paraffin-embedded tumor tissue (FFPE) or circulating-free tumor DNA in peripheral blood samples (liquid biopsy). We offer testing of all major cancer genes, gene panels and exome sequencing (all genes).
We also offer CYP2D6 testing to determine metabolizer status.
We are specialized in Clinical Mass Spectrometry and continuously expand our parameters. We are currently offering:
Stay in contact with us and we keep you informed on our list of parameters, you can also register for our monthly ARCHIMEDlife newsletter.
As a reliable laboratory diagnostic partner we provide Health Care Professionals with a complete testing kit and an easy ordering process.
Please send your request to email@example.com and get your free sample including the DBS card, infosheet and the Informed Consent Form.
Make sure to include the following information for us for a faster handling:
For fast, easy and secure reporting of your test results, please register at ARCHIMEDlife WEBPORTAL.
Diagnostics ・Clinical Studies・Patients’ Care
on 02 Sep, 2020
α-Mannosidosis is an inherited lysosomal storage disorder caused by genetic mutations leading to limited or no expression of a gene responsible for metabolizing oligosaccharides. Although α-Mannosidosis is considered to be ultra-rare, studies...Read More
on 18 Aug, 2020
Fabry disease (FD) is a X-linked inherited disorder where deficiency of the α-Galactosidase A (α-Gal A) enzyme causes Globotriaosylceramide (GL-3/Gb3) lipid accumulation in the cells of different organs. Due to random X-chromosome...Read More
on 04 Aug, 2020
Acid Sphingomyelinase deficiency (ASMD), also known as Niemann-Pick Type A/B, is characterized by an enzyme deficiency that leads to the toxic accumulation of sphingomyelin. “Recent studies show for every 3 – 5...Read More
on 15 Mar, 2020
We stay open for you and your patients! We used the last days to prepare us to continue our work and services on the highest safety and responsibility. Please communicate this to...Read More
on 18 Feb, 2020
Early diagnosis of hemoglobin disorders and Thalassemias are become more important due to a high carrier frequency and ease of global migration. In a prospective study of over 5,000 samples, we investigated...Read More
on 17 Jan, 2020
ARCHIMEDlife is very proud to announce the strategic alliance with amedes Holding GmbH, a leading provider in interdisciplinary and medical-diagnostic services for patients, physicians and hospitals. Together, we will expand and continue...Read More
on 26 Feb, 2019
Quantitative Bestimmung von Psychopharmaka in Blut, Serum oder Plasma Modernste Analysetechnik mittels Klinischer Massenspektrometrie (exakt, sensitiv, schnell) Kompetente fachärztliche Auskunft Tägliche Bestimmungen: Montag – Freitag Download Zuweiserformular *NEU“: Vortioxetin Bestimmung Link: TDMRead More
on 14 Mar, 2018
Our awarded work (Poster Finalist at MSACL Europe, also see the PDF Poster Hemoglobinopathies_MSACL) on hemoglobinopathies and thalassemias is now starting into a prospective study in cooperation with the University Medical Center Hamburg-Eppendorf,...Read More